Table 4 Small-molecule drugs and chemical compounds that regulate gene expression in an opposite manner to BNT162b2.

From: Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes

Compound

Score

Description

Links to hypothalamic-pituitary-ovarian function

Droxinostat

−94.51

HDAC inhibitor

149

Metyrapone

−93.62

Cytochrome P450 inhibitor

150,151

Perospirone

−92.07

Dopamine receptor antagonist

152

Nabumetone

−88.8

Cyclooxygenase inhibitor

153

Salbutamol

−87.35

Adrenergic receptor agonist

154,155

VU-0415374-1

−86.32

Glutamate receptor modulator

156

Bromfenac

−83.64

Cyclooxygenase inhibitor

153,157

PF-3845

−82.22

FAAH inhibitor

158

Hexylresorcinol

−80.48

Local anesthetic

159

PPT

−80.07

Estrogen receptor agonist

160